XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9 | -10.0% | 252 | 0.0% | 0.00% | – |
| Q2 2023 | $10 | +11.1% | 252 | 0.0% | 0.00% | – |
| Q1 2023 | $9 | -10.0% | 252 | 0.0% | 0.00% | – |
| Q4 2022 | $10 | -99.9% | 252 | +27.3% | 0.00% | – |
| Q3 2022 | $7,000 | +16.7% | 198 | 0.0% | 0.00% | – |
| Q2 2022 | $6,000 | +50.0% | 198 | +40.4% | 0.00% | – |
| Q1 2022 | $4,000 | 0.0% | 141 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | +100.0% | 141 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | +100.0% | 141 | +113.6% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 66 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 66 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 66 | -60.0% | 0.00% | – |
| Q3 2019 | $1,000 | -50.0% | 165 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 165 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | – | 165 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
| COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
| ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
| DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
| Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
| Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
| Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
| Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
| BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |